Advanced search
Publication Cover
Clinical, Cosmetic and Investigational Dermatology Volume 17, 2024 - Issue
Submit an article Journal homepage
82
Views
0
CrossRef citations to date
0
Altmetric
RESPONSE TO LETTER

L-Lysine as an Alternative Treatment for Pityriasis Rosea (PR) [Response to Letter]

Luca PotestioSection of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalyORCID Iconhttps://orcid.org/0000-0001-5940-0592
ORCID Icon,
Fabrizio MartoraSection of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalyORCID Iconhttps://orcid.org/0000-0003-2523-050X
ORCID Icon,
Sara CacciapuotiSection of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
,
Matteo MegnaSection of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
,
Alessia VillaniSection of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
&
Angelo RuggieroSection of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4658-7391
ORCID Icon
Pages 463-464 | Received 15 Feb 2024, Accepted 18 Feb 2024, Published online: 28 Feb 2024

References

  • Dos Santos VAB, Pedrazini MC. L-lysine as an alternative treatment for pityriasis rosea (PR) [Letter]. Clin Cosmet Invest Dermatol. 2024;17:433–434. doi:10.2147/CCID.S461722
  • Potestio L, Martora F, Cacciapuoti S, Megna M, Villani A, Ruggiero A. Pityriasis rosea and pityriasis rosea-like eruption following COVID-19 vaccination: a narrative review. Clin Cosmet Invest Dermatol. 2024;17:51–57. doi:10.2147/CCID.S447834
  • Pantry S, Medveczky P. Latency, integration, and reactivation of human herpesvirus-6. Viruses. 2017;9(7):194. doi:10.3390/v9070194
  • Ruggiero A, Megna M, Fabbrocini G, Martora F. Video and telephone teledermatology consultations during COVID-19 in comparison: patient satisfaction, doubts and concerns. Clin Exp Dermatol. 2022;47(10):1863–1864. doi:10.1111/ced.15286
  • Martora F, Villani A, Battista T, Fabbrocini G, Potestio L. COVID-19 vaccination and inflammatory skin diseases. J Cosmet Dermatol. 2023;22(1):32–33. doi:10.1111/jocd.15414
  • Khan I, Elsanousi AA, Shareef AM, Tebha SS, Arif A, Gul S. Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: a systematic review. Immun Inflamm Dis. 2023;11(4):e804. doi:10.1002/iid3.804
  • Pedrazini MC, Silva MH. Pityriasis rosea‐like cutaneous eruption as a possible dermatological manifestation after Oxford‐ASTRAZENECA vaccine: case report and brief literature review. Dermatologic Therapy. 2021;34(6). doi:10.1111/dth.15129
  • Rodriguez-Zuniga M, Torres N, Garcia-Perdomo H. Effectiveness of Acyclovir in the treatment of pityriasis rosea. A systematic review and meta-analysis. An Bras Dermatol. 2018;93(5):686–695. doi:10.1590/abd1806-4841.20187252
  • Villalon-Gomez JM. Pityriasis rosea: diagnosis and treatment. Am Fam Physician. 2018;97(1):38–44.
  • Marasca C, Ruggiero A, Napolitano M, Fabbrocini G, Megna M. May COVID-19 outbreaks lead to a worsening of skin chronic inflammatory conditions? Med Hypotheses. 2020;143:109853. doi:10.1016/j.mehy.2020.109853

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.